SLE-话题@MedSci

#SLE#

235篇内容 | 5024人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1345040, encodeId=8c5c13450401d, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=全球治疗系统性红斑狼疮（SLE）创新双靶生物制剂泰它西普在华率先上市！, objectType=article, longId=209847, objectId=5a7020984efa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a7020984efa, replyNumber=0, likeNumber=73, createdTime=2021-04-13, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a7020984efa, moduleTitle=全球治疗系统性红斑狼疮（SLE）创新双靶生物制剂泰它西普在华率先上市！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a7020984efa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345039, encodeId=d59f134503942, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=JAMA Oncol：Tislelizumab联合化疗作为晚期鳞状非小细胞肺癌的一线治疗方案疗效显著, objectType=article, longId=209616, objectId=c0a520961635, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0a520961635, replyNumber=0, likeNumber=63, createdTime=2021-04-08, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0a520961635, moduleTitle=JAMA Oncol：Tislelizumab联合化疗作为晚期鳞状非小细胞肺癌的一线治疗方案疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0a520961635)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345038, encodeId=d8d71345038cb, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=诺华支付6.5亿美元用于百济神州抗PD-1药物tislelizumab的海外使用权, objectType=article, longId=205683, objectId=7caf20568388, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7caf20568388, replyNumber=0, likeNumber=69, createdTime=2021-01-14, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7caf20568388, moduleTitle=诺华支付6.5亿美元用于百济神州抗PD-1药物tislelizumab的海外使用权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7caf20568388)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345037, encodeId=f3a3134503ead, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=Sleep:睡前玩手机？可要三思了！夜间玩手机与精子质量下降有关, objectType=article, longId=205132, objectId=77a620513222, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77a620513222, replyNumber=0, likeNumber=80, createdTime=2021-01-02, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77a620513222, moduleTitle=Sleep:睡前玩手机？可要三思了！夜间玩手机与精子质量下降有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77a620513222)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345036, encodeId=7511134503602, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle= Sleep Breath：花粉水平能够影响过敏性鼻炎儿童的睡眠呼吸障碍严重度, objectType=article, longId=204776, objectId=ca01204e76d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca01204e76d5, replyNumber=0, likeNumber=0, createdTime=2020-12-24, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca01204e76d5, moduleTitle= Sleep Breath：花粉水平能够影响过敏性鼻炎儿童的睡眠呼吸障碍严重度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca01204e76d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345035, encodeId=3d27134503587, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=J Clin Sleep Med ：失眠睡不好？新研究发现：盖更重的被毯，或能睡得更香, objectType=article, longId=201720, objectId=32a5201e20c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32a5201e20c3, replyNumber=0, likeNumber=62, createdTime=2020-10-07, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32a5201e20c3, moduleTitle=J Clin Sleep Med ：失眠睡不好？新研究发现：盖更重的被毯，或能睡得更香, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32a5201e20c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345034, encodeId=21f0134503487, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=SLEEP 2020：AXS-12（reboxetine）治疗嗜睡症，II期试验结果即将揭晓, objectType=article, longId=200039, objectId=e77f200039b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e77f200039b3, replyNumber=0, likeNumber=111, createdTime=2020-08-31, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e77f200039b3, moduleTitle=SLEEP 2020：AXS-12（reboxetine）治疗嗜睡症，II期试验结果即将揭晓, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e77f200039b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345033, encodeId=4750134503398, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=SLEEP 2020：DAYVIGO（lemborexant）治疗成年失眠，III期临床确认了其有效性和安全性, objectType=article, longId=200038, objectId=5362200038e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5362200038e5, replyNumber=0, likeNumber=0, createdTime=2020-08-31, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5362200038e5, moduleTitle=SLEEP 2020：DAYVIGO（lemborexant）治疗成年失眠，III期临床确认了其有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5362200038e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345032, encodeId=be37134503226, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=SLEEP 2020：失眠患者的福音，Daridorexant的III期临床取得积极进展, objectType=article, longId=200035, objectId=4a2d20003511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a2d20003511, replyNumber=0, likeNumber=145, createdTime=2020-08-31, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a2d20003511, moduleTitle=SLEEP 2020：失眠患者的福音，Daridorexant的III期临床取得积极进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a2d20003511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345031, encodeId=7eac1345031fb, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=Blood：FcγRIIA表达可加重SLE的肾炎和血小板活化, objectType=article, longId=199479, objectId=a3981994e95c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3981994e95c, replyNumber=0, likeNumber=65, createdTime=2020-08-16, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3981994e95c, moduleTitle=Blood：FcγRIIA表达可加重SLE的肾炎和血小板活化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3981994e95c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345030, encodeId=b41f134503017, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=Sleep Medicine：对自己的睡眠满意吗？睡眠对身体的影响可能比你想象得更大, objectType=article, longId=198966, objectId=fa1f198966ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa1f198966ed, replyNumber=0, likeNumber=113, createdTime=2020-08-09, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa1f198966ed, moduleTitle=Sleep Medicine：对自己的睡眠满意吗？睡眠对身体的影响可能比你想象得更大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa1f198966ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345029, encodeId=6aa7134502954, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=Behav Sleep Med：认知行为疗法可改善心力衰竭患者的失眠状况, objectType=article, longId=198491, objectId=902519849162, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=902519849162, replyNumber=0, likeNumber=91, createdTime=2020-08-02, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=902519849162, moduleTitle=Behav Sleep Med：认知行为疗法可改善心力衰竭患者的失眠状况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=902519849162)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345028, encodeId=f2421345028c7, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=重组白介素2 Aldesleukin治疗肌萎缩性侧索硬化症，获得FDA的孤儿药称号, objectType=article, longId=197524, objectId=53cf19e5243c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53cf19e5243c, replyNumber=0, likeNumber=80, createdTime=2020-07-16, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53cf19e5243c, moduleTitle=重组白介素2 Aldesleukin治疗肌萎缩性侧索硬化症，获得FDA的孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53cf19e5243c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345027, encodeId=cb67134502ea8, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=百济神州PD-1单抗Tislelizumab治疗肝细胞癌的新药申请被NMPA接受，以及Tislelizumab抗肿瘤临床研究汇总, objectType=article, longId=196984, objectId=1327196984da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1327196984da, replyNumber=0, likeNumber=76, createdTime=2020-07-04, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1327196984da, moduleTitle=百济神州PD-1单抗Tislelizumab治疗肝细胞癌的新药申请被NMPA接受，以及Tislelizumab抗肿瘤临床研究汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1327196984da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345026, encodeId=ce411345026a9, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=Sleep：认知行为疗法可作为预防抑郁症的一种干预措施, objectType=article, longId=196759, objectId=d612196e59b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d612196e59b1, replyNumber=0, likeNumber=76, createdTime=2020-07-01, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d612196e59b1, moduleTitle=Sleep：认知行为疗法可作为预防抑郁症的一种干预措施, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d612196e59b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345025, encodeId=e65f1345025c4, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=Arthritis Rheumatol：多中心SLE队列的动脉粥样硬化性血管事件, objectType=article, longId=195610, objectId=6c6f195610db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c6f195610db, replyNumber=0, likeNumber=84, createdTime=2020-06-12, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c6f195610db, moduleTitle=Arthritis Rheumatol：多中心SLE队列的动脉粥样硬化性血管事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c6f195610db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345024, encodeId=fa9613450248b, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=血沉&补体，SLE活动风向标！| 健康科普, objectType=article, longId=195007, objectId=546e19500e40, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=546e19500e40, replyNumber=0, likeNumber=64, createdTime=2020-06-01, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=546e19500e40, moduleTitle=血沉&补体，SLE活动风向标！| 健康科普, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=546e19500e40)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345023, encodeId=b4841345023b2, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=Lancet Rheumatol：叶霜教授发现二甲双胍能显著减少SLE患者的复发, objectType=article, longId=192534, objectId=8e8919253436, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e8919253436, replyNumber=0, likeNumber=85, createdTime=2020-04-21, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e8919253436, moduleTitle=Lancet Rheumatol：叶霜教授发现二甲双胍能显著减少SLE患者的复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e8919253436)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345022, encodeId=568c1345022e0, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=J Rheumatol：SLE诊断10年或20年内的肾衰风险, objectType=article, longId=192500, objectId=f6211925002a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6211925002a, replyNumber=0, likeNumber=61, createdTime=2020-04-20, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6211925002a, moduleTitle=J Rheumatol：SLE诊断10年或20年内的肾衰风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6211925002a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345021, encodeId=6e55134502199, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=Arthritis Rheumatol：疾病早期和基线损害低预测SLE患者对贝利木单抗的反应, objectType=article, longId=192278, objectId=64191922e86c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64191922e86c, replyNumber=0, likeNumber=64, createdTime=2020-04-16, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64191922e86c, moduleTitle=Arthritis Rheumatol：疾病早期和基线损害低预测SLE患者对贝利木单抗的反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64191922e86c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SLE

2020-05-29

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

全球治疗系统性红斑狼疮（SLE）创新双靶生物制剂泰它西普在华率先上市！

2021-04-13

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

JAMA Oncol：Tislelizumab联合化疗作为晚期鳞状非小细胞肺癌的一线治疗方案疗效显著

2021-04-08

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

诺华支付6.5亿美元用于百济神州抗PD-1药物tislelizumab的海外使用权

2021-01-14

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Sleep:睡前玩手机？可要三思了！夜间玩手机与精子质量下降有关

2021-01-02

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Sleep Breath：花粉水平能够影响过敏性鼻炎儿童的睡眠呼吸障碍严重度

2020-12-24

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

J Clin Sleep Med ：失眠睡不好？新研究发现：盖更重的被毯，或能睡得更香

2020-10-07

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

SLEEP 2020：AXS-12（reboxetine）治疗嗜睡症，II期试验结果即将揭晓

2020-08-31

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

SLEEP 2020：DAYVIGO（lemborexant）治疗成年失眠，III期临床确认了其有效性和安全性

2020-08-31

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

SLEEP 2020：失眠患者的福音，Daridorexant的III期临床取得积极进展

2020-08-31

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Blood：FcγRIIA表达可加重SLE的肾炎和血小板活化

2020-08-16

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Sleep Medicine：对自己的睡眠满意吗？睡眠对身体的影响可能比你想象得更大

2020-08-09

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Behav Sleep Med：认知行为疗法可改善心力衰竭患者的失眠状况

2020-08-02

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

重组白介素2 Aldesleukin治疗肌萎缩性侧索硬化症，获得FDA的孤儿药称号

2020-07-16

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

百济神州PD-1单抗Tislelizumab治疗肝细胞癌的新药申请被NMPA接受，以及Tislelizumab抗肿瘤临床研究汇总

2020-07-04

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Sleep：认知行为疗法可作为预防抑郁症的一种干预措施

2020-07-01

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Arthritis Rheumatol：多中心SLE队列的动脉粥样硬化性血管事件

2020-06-12

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

血沉&补体，SLE活动风向标！| 健康科普

2020-06-01

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Lancet Rheumatol：叶霜教授发现二甲双胍能显著减少SLE患者的复发

2020-04-21

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

J Rheumatol：SLE诊断10年或20年内的肾衰风险

2020-04-20

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Arthritis Rheumatol：疾病早期和基线损害低预测SLE患者对贝利木单抗的反应

2020-04-16

科室
- - 订阅+
  - 更多科室
工具
服务